Author: eczemarelief
Did you know that in 2022, according to the International Eczema Council, 223 million people were living with eczema? Eczema is a type of inflammatory skin disease that disrupts the skin barrier and its ability to hold moisture. It is the most common chronic skin disease and is genetically transmitted. Eczema affects individuals of all ages, […]
1. Interleukin-23 inhibitors had a lower risk of developing paradoxical eczema when treated for plaque psoriasis compared to TNF inhibitors, IL-17 inhibitors and IL-12/23 2. Clinical features associated with increased paradoxical eczema risks included increasing age, history of atopic dermatitis, and history of hay fever. The risk was also lower in males. Evidence Rating Level: […]
In an analysis of all relevant published studies that assessed atopic dermatitis (also known as eczema) associated with trends in climate-related hazards due to greenhouse gas emissions, investigators found that impacts include direct effects on eczema, like particulate matter-induced inflammation from wildfires, and indirect effects, such as stress resulting from drought-induced food insecurity. In their […]
Prenatal opioid exposure is linked to increased odds of eczema, dermatitis, infections, and asthma, according to a study1 published in JAMA Network Open. Exposure was not linked, however, to allergies, anaphylaxis, or autoimmune conditions. In this study, researchers Kelty et al sought to compare the risk of hospitalization with presentation to emergency departments for children […]